iifl-logo

Dr Reddys Laboratories Ltd Dividend

1,174.8
(-2.14%)
Apr 25, 2025|12:00:00 AM

Dr Reddys Labs CORPORATE ACTIONS

26/04/2024calendar-icon
26/04/2025calendar-icon
PurposeAnnouncement DateEx-DateRecord DateDividend AmountDividend per ShareRemark
Dividend7 May 202416 Jul 2024-40800Final
Recommended a final dividend of Rs. 40/- (800%) per equity share of Rs. 5/- each for the financial year 2023-24. The dividend will be paid on or after five days from the date of declaration of the final dividend by the shareholders at the ensuing 40th Annual General Meeting (AGM) of the Company.

Dr Reddys Labs: Related News

Dr. Reddy’s Laboratories Sells 14 ANDAs to Senores Pharma
5 Mar 2025|11:05 AM

Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.

Read More
Top Stocks for - 27th February 2025
26 Feb 2025|09:22 PM

Here are some of the stocks that may see significant price movement today: KPI Green, Tata Power, UltraTech Cement, etc.

Read More
Dr Reddy’s Hyderabad API Unit Gets USFDA VAI Classification
25 Feb 2025|08:42 PM

Dr Reddy's Laboratories third quarter net profit rose 2.5% year-on-year (YoY) to ₹1,413.3 crore. 

Read More
Dr Reddy’s Laboratories Q3 net profit zooms ~3%
24 Jan 2025|10:23 AM

The company logged a growth of 15.9% in its revenue from operations at ₹8,358.60 Crore versus ₹7,215 Crore in Q3FY24.

Read More
Top Stocks for Today - 24th January 2025
24 Jan 2025|07:50 AM

Here are some of the stocks that may see significant price movement today: Indus Towers, Dr Reddy’s Laboratories, Mankind Pharma, etc.

Read More
Top Stocks for today - 6th December 2024
6 Dec 2024|09:14 AM

Here are some of the stocks that may see significant price movement today: Dr Reddy’s Laboratories, RITES, Canara Bank, etc.

Read More
Dr Reddy’s launches first immuno-onco drug in India
28 Nov 2024|03:43 PM

Dr Reddy's already signed a license and commercialisation deal for Toripalimab with Shanghai Junshi Biosciences Co. Ltd in 2023.

Read More
Dr Reddy’s Bollaram Facility Receives USFDA Form 483 with 7 Observations
21 Nov 2024|11:14 PM

Dr Reddy’s Laboratories shares has gained a total of 5.62% in the last one year, and 2.45% since the beginning of the year.

Read More
Top Stocks for today - 21st November 2024
21 Nov 2024|07:53 AM

Here are some of the stocks that may see significant price movement today: UPL, Tata Power, JSW Steel, Dr Reddy’s, etc.

Read More
Dr Reddy’s posts 15% y-o-y decline in Q2 net profit at ₹1,255 Crore
6 Nov 2024|09:25 AM

EBITDA for the quarter increased 5% year-on-year to ₹2,280 Crore between July and September 2024, while margins improved modestly to 28.4%.

Read More
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.